简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-11-19 10:56 Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
2025-11-18 16:07 European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab
2025-11-18 15:04 Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New "Ideal Japan” Program
2025-11-17 14:13 ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline
2025-11-17 11:02 Ananda Scientific and Benta Sign Memorandum on Advancing Treatments for PTSD
2025-11-17 10:50 Stealth Third Rock Ventures Backed Company Selects Parse Biosciences GigaLab to Build Largest TCR Atlas for Common Autoimmune Disease
2025-11-14 15:40 Galderma Completes Successful Placement of CHF 175 Million Bond
2025-11-14 14:15 Mary Kay Ash Foundation® Gifts $500,000 Grant to Advance Cancer Research and Early Detection at Baylor Scott & White Health
2025-11-14 12:59 JSR Life Sciences Enters Definitive Agreement to Transfer Crown Bioscience to Adicon Holdings Limited
2025-11-13 19:05 InterSystems Launches HealthShare AI Assistant to Optimize Data Retrieval and Clinical Engagement with Conversational Intelligence
2025-11-13 11:00 InterSystems Launches HealthShare AI Assistant to Optimize Data Retrieval and Clinical Engagement with Conversational Intelligence
2025-11-13 10:42 FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma
2025-11-12 15:04 NEL Animal Medical Foundation Named ‘Asia’s Best Animal Hospital’ for Excellence in Heart Valve Surgery at Asia's Best Animal Hospital Awards 2025
2025-11-11 10:50 Samsung Epis Holdings Announces Establishment of Epis NexLab, a New Subsidiary to Advance Next-Generation Biotechnology Platforms
2025-11-10 11:35 Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie
2025-11-10 10:51 Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy
2025-11-10 10:28 BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates
2025-11-07 19:02 NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services
2025-11-07 10:58 BOSTON ONCOLOGY ARABIA and LOCAL CONTENT & GOVERNMENT PROCUREMENT AUTHORITY Sign Agreement to Localize Advanced Biologic Medicines in Saudi Arabia
2025-11-06 15:20 Registrar Corp Acquires CMC Medical Devices to Make Global Compliance Quick and Easy

Business Wire Weibo

Press Releases

Latest Releases